Next Science | NXS - Capitale Sociale E Riserve



Capitale Sociale E Riserve Cambiamento Data
Alcidion AUD 89.64M 1.84M 2025-12
Ansell USD 1.97B 10.2M 2025-12
Fisher & Paykel Healthcare NZD 1.99B 95.8M 2025-12
Mayne Pharma AUD 454.19M 93.58M 2024-06
Nanosonics AUD 219.69M 9.78M 2025-12
Polynovo AUD 83.14M 121K 2025-12
ResMed USD 6.32B 199.62M 2025-12